XML 37 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Significant Accounting Policies and Concentrations of Risk (Tables)
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Summary of Revenues
The Company recorded the following revenues for the three and six months ended June 30, 2024 and 2023 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Product sales, net$107,987 $80,504 $197,259 $148,670 
Collaborative and other revenues1,345 1,987 4,834 2,599 
Total revenues$109,332 $82,491 $202,093 $151,269 
The Company recorded the following revenues for the three and six months ended June 30, 2024 and 2023 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
ORLADEYO:
U.S.$95,909 $72,817 $175,875 $133,666 
Outside of U.S.12,379 8,192 21,280 15,757 
Total ORLADEYO108,288 81,009 197,155 149,423 
Other revenues1,044 1,482 4,938 1,846 
Total revenues$109,332 $82,491 $202,093 $151,269 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The Company excluded the following potential common shares, presented based on amounts outstanding as of June 30, 2024 and June 30, 2023, from the computation of diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2024 and 2023 because including them would have had an anti-dilutive effect:
June 30,
20242023
Outstanding stock options39,013 35,564 
Unvested restricted stock unit awards5,986 4,621 
Warrants to purchase common stock— 15,023 
Total44,999 55,208